MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
about
Critical and functional regulation of CHOP (C/EBP homologous protein) through the N-terminal portionCoordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR elementCharge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm traffickingMAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agentsHDM2-binding partners: interaction with translation elongation factor EF1alpha.Negative regulation of p53 functions by Daxx and the involvement of MDM2Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cellsStructural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domainCrosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA bindingChfr is linked to tumour metastasis through the downregulation of HDAC1Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cellsMultiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3'-end processingp53 deacetylation by SIRT1 decreases during protein kinase CKII downregulation-mediated cellular senescenceHuman PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancerHistone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradationCorepressor MMTR/DMAP1 is involved in both histone deacetylase 1- and TFIIH-mediated transcriptional repressionRegulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylationHepatocarcinogenic potential of the glucocorticoid antagonist RU486 in B6C3F1 mice: effect on apoptosis, expression of oncogenes and the tumor suppressor gene p53HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory DiseasesExpanding the ubiquitin code through post-translational modificationMdm2 as a chromatin modifierThe role of prostate tumor overexpressed 1 in cancer progressionp53 Acetylation: Regulation and ConsequencesThe promise and perils of HDAC inhibitors in neurodegenerationCyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitmentHistone deacetylases and cancerDietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cellsTransforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradationPurified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitroE2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitroDrosophila histone deacetylase-3 controls imaginal disc size through suppression of apoptosisHistone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcriptionHistone deacetylase 2 (HDAC2) regulates chromosome segregation and kinetochore function via H4K16 deacetylation during oocyte maturation in mouseAn essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger productionIntegrating genomics and proteomics data to predict drug effects using binary linear programming
P2860
Q24293712-F6EED457-5789-4268-99B9-D98EE3081638Q24295165-1ADC4715-6D2A-449A-93A3-46293BD1FB49Q24295186-1307B573-2513-433A-A517-51ED16D8F5B1Q24297439-3E2549FB-04C5-4950-96AC-A28E1642FB8AQ24300548-5620CA77-94CA-4852-A316-797157B1A3E1Q24303893-88E20038-7831-416F-BF66-A7C4D36F54EDQ24306316-E581D097-A4E4-414F-8CBE-8C8786819F74Q24307469-74A31577-7770-41E2-AFF9-37CA161F6896Q24307750-603F8EC5-D2B3-4C76-9D02-D45323ED2978Q24311550-73F64CDF-8E2F-472E-B8F7-AAA5464DBA3DQ24311663-DEF60C05-4C22-4B97-A324-7DC6E32784FBQ24324032-A8274E5A-A76F-49C8-A498-E5EE31AFC865Q24324035-1279EF4E-12D4-4CBD-AE99-0A9AE2D8E29EQ24324150-A8DC0A56-9662-4CC6-A7A8-9086C729FAC4Q24328749-C6965EC6-3909-4E85-92C5-85189E5B3414Q24336227-5D33AC64-5F08-4BBF-8305-70E7B806F1E4Q24337103-4853FCBA-EBFD-4E83-9104-B58CD07E3A7BQ24339391-7788C492-2A94-46E6-961B-4513F4E0B2A3Q24670460-83E715A6-C1FB-47BF-9DC8-6ED07BDC9945Q24671304-6B79D208-AE4F-4690-B533-A782F66C401BQ24683232-5267D3B0-117C-4847-AD42-5257BCD2450DQ24793292-3A4A2AE5-E5B9-4F22-A3BE-69B7CEEDCC40Q24800095-7C0694AB-BA45-413F-8DAF-48EA7FF29AA3Q26739120-645AE00E-FF54-4AA5-AEAE-44FD9AEDB5A0Q26798369-F7532AAA-EED7-4B17-A415-77E34749DF8DQ28073903-ADA61920-9960-43FB-A4E0-CDC258CE30EAQ28079350-339BE56F-93CB-43F5-AA1F-8BE5347044C1Q28085076-5ACCCEE4-2712-4D32-B9A1-341EDAD2B1EBQ28087539-1F451462-4D95-4D50-B33B-C5D96F92B6E5Q28235209-549355DA-3849-4D5D-AD20-3A5C9757EF61Q28240447-86D73FC4-04EA-4681-9BD5-D8C243F8D877Q28257534-403581EC-283F-4CFA-A686-8AA071058B35Q28261166-5C43257F-1B96-41DD-AB76-AA0E086C0EB6Q28299149-9741828A-C065-413E-948A-2443CF517D38Q28393378-D21039C6-0D23-4DE9-859E-D53F0356BE41Q28472324-FA469BD8-E2AE-47AF-9547-7C6C96E789A5Q28505369-AA7D67FA-EC73-40E1-B362-B2C7B0B3ACAAQ28506706-239D5607-2E31-44A9-8687-9F2B58D0AEAAQ28513065-50EB7A38-676C-4BBB-9C8F-3AC07A698980Q28540932-EE40D715-06F7-490B-9CC3-A65C99EA733B
P2860
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@ast
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@en
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@nl
type
label
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@ast
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@en
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@nl
prefLabel
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@ast
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@en
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@nl
P2093
P2860
P3181
P356
P1433
P1476
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
@en
P2093
Akihiro Ito
Chun-Hsiang Lai
Jeffrey J Kovacs
Tso-Pang Yao
Yoshiharu Kawaguchi
Yuichiro Higashimoto
P2860
P304
P3181
P356
10.1093/EMBOJ/CDF616
P407
P577
2002-11-15T00:00:00Z